Company / R&D per Share
INOVIO PHARMACEUTICALS, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.09
FY2025
5-year range
$0.43 / $11.82
FY2021-FY2025
Trend
-44.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.43 in FY2022 to $11.82 in FY2023.
Based on SEC 10-K filings.
2.09 in FY2025 with a 5-year CAGR of +17.4%.
Declined from $11.82 to $2.09 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +69.1%
- 5-Year CAGR
- +17.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 44.9% year-over-year.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.09 | -44.9% |
| FY2024 | $3.80 | -67.8% |
| FY2023 | $11.82 | +2625.8% |
| FY2022 | $0.43 | -8.0% |
| FY2021 | $0.47 | -49.9% |
| FY2020 | $0.94 | -7.3% |
| FY2019 | $1.01 | +3.3% |
| FY2018 | $0.98 | +25.8% |
| FY2017 | $0.78 | +65.3% |
| FY2016 | $0.47 | +34.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026